Investors, Private Equity & M&A: lists

42 list previews in Investors, Private Equity & M&A. Sample rows are free; lists marked as available can be bought as CSV, the others by reservation.

Seed and Early-Stage Biotech & Life-Science Investors: 154 VC Firms, Corporate VCs, Venture Studios and Accelerators in 24 Countries - Each With the Firm's Own Statement of Its Stage and Sector Focus (Partial List)

154 investment organisations that say on their own website that they invest in, found or accelerate seed, early-stage or Series A biotech, therapeutics or life-science companies: venture capital firms, corporate venture arms, venture studios / company creators, accelerators and university-linked or public seed investors. Head offices: United States 56, Europe 63, Asia-Pacific and Middle East 26, Canada 9. One row per organisation with head-office country and city, firm type, the stage and sector focus in the words of the firm's own statement, the page and the exact wording, plus up to 3 portfolio companies named on the firm's own portfolio page (40 rows) and the latest Form D found on SEC EDGAR for one of its funds (62 rows). Organisations only: no partner names, no contact details. Not a complete list of such investors; it is the firms whose statements we could confirm on their own sites, as of 2026-10-12.

Full list available · CSVInvestors, Private Equity & M&A